![Duane A. Morris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Duane A. Morris
Director de Operaciones en
C3J Therapeutics, Inc.
.
Perfil
Duane A. Morris is currently the Vice President-Operations at C3J Therapeutics, Inc. He previously held positions as the Director-Pharmaceutical Manufacturing at Syntex Corp, Manufacturing Director at Syntex Laboratories, Inc., Vice President-Operations at ID Biomedical Corp., Vice President-Operations at Cypress Bioscience, Inc., Chief Operating Officer at Response Biomedical Corp., Vice President-Production & Facilities at C3 Jian LLC, General Manager at GlaxoSmithKline Biologicals NV, and General Manager & Vice President at GSK Products, Inc. Mr. Morris obtained his undergraduate degree from the College of Saint Mary.
Cargos activos de Duane A. Morris
| Empresas | Cargo | Inicio |
|---|---|---|
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Director de Operaciones | 01/01/2012 |
Antiguos cargos conocidos de Duane A. Morris.
| Empresas | Cargo | Fin |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director de Operaciones | 01/05/2023 |
| RESPONSE BIOMEDICAL CORP | Director de Operaciones | 29/10/2010 |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | 25/02/2009 |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Corporate Officer/Principal | 01/12/2006 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Director de Operaciones | 01/01/2005 |
Formación de Duane A. Morris.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
40
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
Response Biomedical Corp.
 Response Biomedical Corp. Medical SpecialtiesHealth Technology Develops acute care diagnostic testing products | Health Technology |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections | Health Technology |
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
GSK Products, Inc.
 GSK Products, Inc. Wholesale DistributorsDistribution Services Beauty & barber supply concern | Distribution Services |
College of Saint Mary
 College of Saint Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syntex Laboratories, Inc. | |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
- Bolsa de valores
- Insiders
- Duane A. Morris
